130 related articles for article (PubMed ID: 2537384)
1. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
[TBL] [Abstract][Full Text] [Related]
2. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
3. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
[TBL] [Abstract][Full Text] [Related]
4. Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994.
Lebitasy MP; Hédelin G; Purohit A; Moreau L; Klinzig F; Quoix E
Br J Cancer; 2001 Sep; 85(6):808-15. PubMed ID: 11556829
[TBL] [Abstract][Full Text] [Related]
5. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in small cell lung cancer: multivariate analysis in the National Cancer Center Hospital (Japan).
Shinkai T; Sakurai M; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Fukuda M; Yamada K; Kojima A; Sasaki S
Jpn J Clin Oncol; 1989 Jun; 19(2):135-41. PubMed ID: 2543848
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer: analysis of factors influencing the response to treatment and survival.
de Wet M; Falkson G; Rapoport BL
Oncology; 1994; 51(6):523-34. PubMed ID: 7970498
[TBL] [Abstract][Full Text] [Related]
9. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Albain KS; Crowley JJ; Livingston RB
Chest; 1991 Jun; 99(6):1425-32. PubMed ID: 2036826
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].
Lü JM; Liang J; Wang JW; He J; Xiao ZF; Zhang HX; Chen DF; Feng QF; Wang LH
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):121-5. PubMed ID: 19538888
[TBL] [Abstract][Full Text] [Related]
13. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
[TBL] [Abstract][Full Text] [Related]
15. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
17. [How should we treat elderly patients with small cell lung cancer?--information gathered by questionnaires and analysis of 351 patients aged 70 or over. West Japan Thoracic Oncology Group].
Gan To Kagaku Ryoho; 1999 May; 26(6):797-804. PubMed ID: 10410149
[TBL] [Abstract][Full Text] [Related]
18. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
[TBL] [Abstract][Full Text] [Related]
19. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants.
Osterlind K; Hansen HH; Hansen M; Dombernowsky P; Andersen PK
J Clin Oncol; 1986 Sep; 4(9):1307-13. PubMed ID: 3018182
[TBL] [Abstract][Full Text] [Related]
20. Influence of age on the treatment of limited-stage small-cell lung cancer.
Siu LL; Shepherd FA; Murray N; Feld R; Pater J; Zee B
J Clin Oncol; 1996 Mar; 14(3):821-8. PubMed ID: 8622030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
